November 21, 2017
Payouts are becoming more popular in the sector, which means income investors may want to give biotech stocks another look.
January 3, 2017
No doubt about it—2016 was a tumultuous year for biotech. But that doesn’t mean you should be afraid of this...
December 12, 2016
One thing’s clear: if pharmaceutical companies want to remain profitable, they’ll need to tweak their business strategy in 2017.
December 8, 2016
Pharmaceutical companies have developed numerous strategies to counter the patent cliff. One such tactic? Capitalizing on the personalized medicine market....
October 31, 2016
Once a drug patent expires, a generic drug company can manufacture a generic bioequivalent. What does that mean for consumers?...
April 25, 2016
A nutraceutical industry overview – a look at what is shaping the market.
October 2, 2015
According to Motley Fool, a pharmaceutical patent cliff is poised to set in next year. AstraZeneca's (NUSE:AZN) current efforts to...